Cite
HARVARD Citation
King, B. et al. (2016). Low‐dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA. Journal of neurochemistry. 137 (3), pp. 409-422. [Online].